Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Grant or award Director acquired 11,000 shares (grant or award)
  2. 4 Grant or award President acquired 207,201 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
  4. 4 Grant or award Director acquired 5,501 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 6,392 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award Chief Executive Officer acquired 5,784 shares (grant or award)
  8. 4 Grant or award Chief Executive Officer acquired 6,339 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Director acquired 10,416 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Director acquired 41,666 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 8,264 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 8,476 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 6,420 shares (grant or award)
  16. 4 Grant or award Chief Executive Officer acquired 4,630 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Chief Executive Officer acquired 3,300 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 3,055 shares (grant or award)
  20. 4 Grant or award Chief Executive Officer acquired 3,317 shares (grant or award)

Page 3 of 14 · 261 filings